Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients

BACKGROUND: Over 20 % of ovarian cancer patients have preoperative thrombocytosis or hyperfibrinogenemia. We aimed to demonstrate the clinical and prognostic significance of thrombocytosis and hyperfibrinogenemia in high-grade serous ovarian cancer (HGSC). METHODS: We retrospectively investigated HG...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zheng, Wen, Hao, Bi, Rui, Duan, Yachen, Yang, Wentao, Wu, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730624/
https://www.ncbi.nlm.nih.gov/pubmed/26817451
http://dx.doi.org/10.1186/s12885-016-2070-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730624/
https://www.ncbi.nlm.nih.gov/pubmed/26817451
http://dx.doi.org/10.1186/s12885-016-2070-2

Ejemplares similares